Published in Trends Cell Biol on April 25, 2015
CasExpress reveals widespread and diverse patterns of cell survival of caspase-3 activation during development in vivo. Elife (2016) 0.87
Interleukin-10 plays a key role in the modulation of neutrophils recruitment and lung inflammation during infection by Streptococcus pneumoniae. Immunology (2015) 0.84
MicroRNAs as regulators of apoptosis mechanisms in cancer. Clujul Med (2016) 0.81
CdSe/ZnS quantum dots induce photodynamic effects and cytotoxicity in pancreatic cancer cells. World J Gastroenterol (2016) 0.77
Cytotoxic effects of SMAC-mimetic compound LCL161 in head and neck cancer cell lines. Clin Oral Investig (2016) 0.76
miR-181 interacts with signaling adaptor molecule DENN/MADD and enhances TNF-induced cell death. PLoS One (2017) 0.75
Apoptosis of human gastric carcinoma cells induced by Euphorbia esula latex. World J Gastroenterol (2016) 0.75
Differential Impacts of Alternative Splicing Networks on Apoptosis. Int J Mol Sci (2016) 0.75
Prognostic relevance of caspase 8 -652 6N InsDel and Asp302His polymorphisms for breast cancer. BMC Cancer (2016) 0.75
Dynamic proteomics reveals bimodal protein dynamics of cancer cells in response to HSP90 inhibitor. BMC Syst Biol (2017) 0.75
Bcl-2 proteins bid and bax form a network to permeabilize the mitochondria at the onset of apoptosis. Cell Death Dis (2016) 0.75
Bacterial persistence as a phenotypic switch. Science (2004) 15.80
Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell (1998) 13.87
Nature, nurture, or chance: stochastic gene expression and its consequences. Cell (2008) 12.13
A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations. Cell (2010) 11.20
Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. Cancer Cell (2002) 11.09
Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell (2003) 11.07
Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat Immunol (2000) 8.49
Tumor necrosis factor signaling. Cell Death Differ (2003) 8.48
Oscillations in NF-kappaB signaling control the dynamics of gene expression. Science (2004) 8.44
X-linked IAP is a direct inhibitor of cell-death proteases. Nature (1997) 8.26
Noise propagation in gene networks. Science (2005) 8.19
Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors. Nature (2012) 8.13
Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J (1995) 7.60
Transcriptome-wide noise controls lineage choice in mammalian progenitor cells. Nature (2008) 7.60
Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosis. Nature (2009) 7.24
Functional roles for noise in genetic circuits. Nature (2010) 6.96
Intra-tumour heterogeneity: a looking glass for cancer? Nat Rev Cancer (2012) 6.82
Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1. Nature (2003) 6.78
A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth. Cell (2010) 6.47
Variability and memory of protein levels in human cells. Nature (2006) 6.15
A unified model for apical caspase activation. Mol Cell (2003) 6.12
How do BCL-2 proteins induce mitochondrial outer membrane permeabilization? Trends Cell Biol (2008) 6.02
Enhancement of cellular memory by reducing stochastic transitions. Nature (2005) 6.01
Cullin3-based polyubiquitination and p62-dependent aggregation of caspase-8 mediate extrinsic apoptosis signaling. Cell (2009) 5.55
Dynamic proteomics of individual cancer cells in response to a drug. Science (2008) 5.43
Single-cell NF-kappaB dynamics reveal digital activation and analogue information processing. Nature (2010) 5.27
Role of Bax and Bak in mitochondrial morphogenesis. Nature (2006) 5.25
Disease tolerance as a defense strategy. Science (2012) 5.22
Variable clonal repopulation dynamics influence chemotherapy response in colorectal cancer. Science (2012) 4.92
The CD95(APO-1/Fas) DISC and beyond. Cell Death Differ (2003) 4.72
Stochasticity and cell fate. Science (2008) 4.39
Caspase activity and a specific cytochrome C are required for sperm differentiation in Drosophila. Dev Cell (2003) 4.23
Inflammatory caspases and inflammasomes: master switches of inflammation. Cell Death Differ (2006) 4.16
Pulsatile stimulation determines timing and specificity of NF-kappaB-dependent transcription. Science (2009) 4.14
Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL. Nat Med (2007) 3.99
Quantitative analysis of pathways controlling extrinsic apoptosis in single cells. Mol Cell (2008) 3.88
Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma. Nature (2014) 3.80
DNA damage response and MCL-1 destruction initiate apoptosis in adenovirus-infected cells. Genes Dev (2003) 3.67
Multiplexed mass cytometry profiling of cellular states perturbed by small-molecule regulators. Nat Biotechnol (2012) 3.65
Death receptor signal transducers: nodes of coordination in immune signaling networks. Nat Immunol (2009) 3.63
Using gene expression noise to understand gene regulation. Science (2012) 3.49
Self-consumption: the interplay of autophagy and apoptosis. Nat Rev Mol Cell Biol (2014) 3.38
Variability and robustness in T cell activation from regulated heterogeneity in protein levels. Science (2008) 3.38
p53 dynamics control cell fate. Science (2012) 3.30
Ubiquitin-protein ligase activity of X-linked inhibitor of apoptosis protein promotes proteasomal degradation of caspase-3 and enhances its anti-apoptotic effect in Fas-induced cell death. Proc Natl Acad Sci U S A (2001) 3.19
Timescales of genetic and epigenetic inheritance. Cell (2007) 3.10
XIAP discriminates between type I and type II FAS-induced apoptosis. Nature (2009) 3.00
RIP1, a kinase on the crossroads of a cell's decision to live or die. Cell Death Differ (2007) 2.96
Cytochrome c: functions beyond respiration. Nat Rev Mol Cell Biol (2008) 2.95
c-FLIP(L) is a dual function regulator for caspase-8 activation and CD95-mediated apoptosis. EMBO J (2002) 2.91
Caspase 3 activity is required for skeletal muscle differentiation. Proc Natl Acad Sci U S A (2002) 2.88
The long form of FLIP is an activator of caspase-8 at the Fas death-inducing signaling complex. J Biol Chem (2002) 2.75
Caspase activation is required for T cell proliferation. J Exp Med (1999) 2.74
Inhibition of PI3K/mTOR leads to adaptive resistance in matrix-attached cancer cells. Cancer Cell (2012) 2.71
Non-genetic heterogeneity--a mutation-independent driving force for the somatic evolution of tumours. Nat Rev Genet (2009) 2.69
Local caspase activity directs engulfment of dendrites during pruning. Nat Neurosci (2006) 2.65
Cellular heterogeneity and molecular evolution in cancer. Annu Rev Pathol (2012) 2.56
New insights into apoptosis signaling by Apo2L/TRAIL. Oncogene (2010) 2.56
Membrane-bound Fas ligand only is essential for Fas-induced apoptosis. Nature (2009) 2.54
TRAIL signalling: decisions between life and death. Int J Biochem Cell Biol (2007) 2.49
CD95 promotes tumour growth. Nature (2010) 2.42
Life and death by death receptors. FASEB J (2009) 2.39
The proliferation-quiescence decision is controlled by a bifurcation in CDK2 activity at mitotic exit. Cell (2013) 2.37
Apoptotic cells activate the "phoenix rising" pathway to promote wound healing and tissue regeneration. Sci Signal (2010) 2.36
Life and death decisions: secondary complexes and lipid rafts in TNF receptor family signal transduction. Immunity (2004) 2.36
The CD95 type I/type II model. Semin Immunol (2003) 2.34
TRAIL-induced apoptosis requires Bax-dependent mitochondrial release of Smac/DIABLO. Genes Dev (2002) 2.31
Gene expression profiling of mammary gland development reveals putative roles for death receptors and immune mediators in post-lactational regression. Breast Cancer Res (2003) 2.29
Reconstitution of the death-inducing signaling complex reveals a substrate switch that determines CD95-mediated death or survival. Mol Cell (2009) 2.24
Yes and PI3K bind CD95 to signal invasion of glioblastoma. Cancer Cell (2008) 2.21
Origins of regulated cell-to-cell variability. Nat Rev Mol Cell Biol (2011) 2.15
Drosophila IKK-related kinase regulates nonapoptotic function of caspases via degradation of IAPs. Cell (2006) 2.15
CD95 ligand induces motility and invasiveness of apoptosis-resistant tumor cells. EMBO J (2004) 2.12
Identifying single-cell molecular programs by stochastic profiling. Nat Methods (2010) 2.11
Frequency-modulated pulses of ERK activity transmit quantitative proliferation signals. Mol Cell (2012) 2.11
Relief of extrinsic pathway inhibition by the Bid-dependent mitochondrial release of Smac in Fas-mediated hepatocyte apoptosis. J Biol Chem (2002) 2.10
Measuring and modeling apoptosis in single cells. Cell (2011) 2.10
Rapid and sustained nuclear-cytoplasmic ERK oscillations induced by epidermal growth factor. Mol Syst Biol (2009) 2.10
Targeting the extrinsic apoptosis pathway in cancer. Cytokine Growth Factor Rev (2008) 2.08
Death versus survival: functional interaction between the apoptotic and stress-inducible heat shock protein pathways. J Clin Invest (2005) 2.06
Membrane oligomerization and cleavage activates the caspase-8 (FLICE/MACHalpha1) death signal. J Biol Chem (1998) 2.06
Survival function of the FADD-CASPASE-8-cFLIP(L) complex. Cell Rep (2012) 2.06
A two-dimensional ERK-AKT signaling code for an NGF-triggered cell-fate decision. Mol Cell (2011) 2.02
Insights into the regulatory mechanism for caspase-8 activation. Mol Cell (2003) 2.01
Drug resistance via feedback activation of Stat3 in oncogene-addicted cancer cells. Cancer Cell (2014) 1.96
Distinct signaling pathways in TRAIL- versus tumor necrosis factor-induced apoptosis. Mol Cell Biol (2006) 1.88
Molecular determinants of kinase pathway activation by Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand. J Biol Chem (2005) 1.87
A sequential two-step mechanism for the production of the mature p17:p12 form of caspase-3 in vitro. J Biol Chem (1997) 1.82
Patterns of basal signaling heterogeneity can distinguish cellular populations with different drug sensitivities. Mol Syst Biol (2010) 1.77
Metrics other than potency reveal systematic variation in responses to cancer drugs. Nat Chem Biol (2013) 1.75
Dynamic expression of epidermal caspase 8 simulates a wound healing response. Nature (2009) 1.71
TRAIL promotes the survival and proliferation of primary human vascular endothelial cells by activating the Akt and ERK pathways. Circulation (2003) 1.71
Apoptotic and non-apoptotic roles of caspases in neuronal physiology and pathophysiology. Nat Rev Neurosci (2012) 1.69
Population robustness arising from cellular heterogeneity. Proc Natl Acad Sci U S A (2010) 1.66
Caspase 3/caspase-activated DNase promote cell differentiation by inducing DNA strand breaks. Proc Natl Acad Sci U S A (2010) 1.65
A death effector domain chain DISC model reveals a crucial role for caspase-8 chain assembly in mediating apoptotic cell death. Mol Cell (2012) 1.64
Fas engagement accelerates liver regeneration after partial hepatectomy. Nat Med (2000) 1.60
Dynamics within the CD95 death-inducing signaling complex decide life and death of cells. Mol Syst Biol (2010) 1.57
Stoichiometry of the CD95 death-inducing signaling complex: experimental and modeling evidence for a death effector domain chain model. Mol Cell (2012) 1.57
TRAIL induced survival and proliferation in cancer cells resistant towards TRAIL-induced apoptosis mediated by NF-kappaB. Oncogene (2003) 1.57